abstract |
The invention relates to compounds selected from the group consisting of the formulas: <IMAGE> A <IMAGE> B <IMAGE> C wherein R2 and Ph are as described herein. These compounds are potent leukotriene B4 antagonists and are therefore useful in the treatment of inflammatory diseases. |